ARCHIVES

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

This article is from The Cancer Letter archive.

Vol. 35 No. 13 | April 3, 2009

Download PDF Visit The Full Archive

Related Articles

Cyramza Combination Approved In Advanced Gastric Cancer

November 28, 2014

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Blood Cancers Advocacy Groups Seek DOD And NCI Funds, Medicare Coverage.

July 6, 2001

The March: AACR, AACI Compile List Of Activities Related To The March

May 8, 1998

Also Stillman named director, Cold Spring Harbor, Watson is chancellor.

December 12, 2003

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009